{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+400+mg&page=7", "query": { "intervention": "Placebo 400 mg", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 1034, "total_pages": 104, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+400+mg&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+400+mg&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T14:21:51.243Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05896527", "title": "A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "DC-806", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 229, "start_date": "2023-05-02", "completion_date": "2024-03-25", "has_results": true, "last_update_posted_date": "2025-04-04", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 13, "location_summary": "Fountain Valley, California • Santa Monica, California • Coral Gables, Florida + 10 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Naples", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05896527" }, { "nct_id": "NCT00563394", "title": "MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Foot Ulcers" ], "interventions": [ { "name": "ofloxacin", "type": "DRUG" }, { "name": "MSI-78", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abeona Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 584, "start_date": "1994-08", "completion_date": "1996-07", "has_results": false, "last_update_posted_date": "2020-09-03", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00563394" }, { "nct_id": "NCT05712356", "title": "A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cholangiocarcinoma", "Gallbladder Cancer", "Gallbladder Carcinoma", "Intrahepatic Cholangiocarcinoma", "Extrahepatic Cholangiocarcinoma", "Bile Duct Cancer", "Gall Bladder Cancer", "Gall Bladder Carcinoma" ], "interventions": [ { "name": "certepetide", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "FOLFOX regimen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lisata Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2023-05-13", "completion_date": "2026-04-05", "has_results": true, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 19, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 15 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tampa", "state": "Florida" }, { "city": "Merriam", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05712356" }, { "nct_id": "NCT01629667", "title": "A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Idiopathic Pulmonary Fibrosis" ], "interventions": [ { "name": "Tralokinumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "50 Years to 79 Years" }, "enrollment_count": 409, "start_date": "2012-10", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 21, "location_summary": "Phoenix, Arizona • La Jolla, California • Sacramento, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Winter Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01629667" }, { "nct_id": "NCT01258777", "title": "A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "400 mg golimumab or placebo", "type": "DRUG" }, { "name": "200 mg golimumab or placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 49, "start_date": "2010-10", "completion_date": "2011-04", "has_results": false, "last_update_posted_date": "2013-09-04", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01258777" }, { "nct_id": "NCT00308581", "title": "Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Certolizumab pegol", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 539, "start_date": "2006-04", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2018-08-07", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 31, "location_summary": "San Francisco, California • Gainesville, Florida • Atlanta, Georgia + 28 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308581" }, { "nct_id": "NCT06531395", "title": "A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjögrens Disease" ], "interventions": [ { "name": "Abiprubart", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kiniksa Pharmaceuticals International, plc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 3, "start_date": "2024-07-17", "completion_date": "2025-05-01", "has_results": false, "last_update_posted_date": "2025-05-21", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 16, "location_summary": "Menifee, California • Poway, California • Whittier, California + 13 more", "locations": [ { "city": "Menifee", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "Whittier", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "DeBary", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06531395" }, { "nct_id": "NCT03452488", "title": "A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcopenia", "Gait Disorders in Old Age", "Muscle Weakness" ], "interventions": [ { "name": "BIO101", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biophytis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 233, "start_date": "2017-02-07", "completion_date": "2020-04-26", "has_results": true, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 19, "location_summary": "Banning, California • Garden Grove, California • San Diego, California + 15 more", "locations": [ { "city": "Banning", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03452488" }, { "nct_id": "NCT04885530", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 10956, "start_date": "2021-06-08", "completion_date": "2024-04-29", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 110, "location_summary": "Chandler, Arizona • Gilbert, Arizona • Mesa, Arizona + 96 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04885530" }, { "nct_id": "NCT01376557", "title": "Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "75 mg LX4211", "type": "DRUG" }, { "name": "200 mg LX4211", "type": "DRUG" }, { "name": "400 mg LX4211", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lexicon Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 299, "start_date": "2011-06", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2014-10-31", "last_synced_at": "2026-10-06T14:21:51.243Z", "location_count": 56, "location_summary": "Anaheim, California • Carmichael, California • Greenbrae, California + 48 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Carmichael", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01376557" } ] }